M
Magnus Unemo
Researcher at Örebro University
Publications - 465
Citations - 22073
Magnus Unemo is an academic researcher from Örebro University. The author has contributed to research in topics: Neisseria gonorrhoeae & Antibiotic resistance. The author has an hindex of 62, co-authored 418 publications receiving 17623 citations. Previous affiliations of Magnus Unemo include World Health Organization.
Papers
More filters
Journal ArticleDOI
2020 European guideline on the management of syphilis.
TL;DR: The 2020 edition of the European guideline on the management of syphilis is an update of the 2014 edition.
Journal ArticleDOI
The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils.
Magnus Unemo,Marina Aspholm-Hurtig,Dag Ilver,Jörgen Bergström,Thomas Borén,Dan Danielsson,Susann Teneberg +6 more
TL;DR: It is suggested that the sialic acid-binding SabA adhesin is a prerequisite for the nonopsonic activation of human neutrophils and, thus, is a virulence factor important for the pathogenesis of H. pylori infection.
Journal ArticleDOI
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure
David A. Lewis,David A. Lewis,David A. Lewis,Charlotte Sriruttan,Etienne E. Müller,Daniel Golparian,Lindy Gumede,Donald Fick,Johan de Wet,Venessa Maseko,Jennifer Coetzee,Magnus Unemo +11 more
TL;DR: The first two cases of extended-spectrum cephalosporin (ESC)-resistant Neisseria gonorrhoeae in South Africa were associated with verified cefixime treatment failure and contained the type XXXIV penA mosaic allele and belonged to a successful international MSM-linked multidrug-resistant gonococcal clone (MLST ST1901) associated with several cefIXime treatment failures in Europe and North America.
Journal ArticleDOI
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: Role of epistatic mutations
TL;DR: The proposed structural mechanisms of these mutations are discussed in light of the recently published structure of PBP 2, and an additional mutation, N512Y, is identified that contributes to the decreased susceptibility to expanded-spectrum cephalosporins.
Journal ArticleDOI
Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
TL;DR: The second case in Europe of verified treatment failure of pharyngeal gonorrhoea, caused by an internationally occurring multidrug-resistant gonococcal clone, with recommended first-line ceftriaxone 250 mg in Slovenia is described.